FDA inspection
Jell Pharmaceuticals Pvt. Ltd.: FDA inspection ending Mar 17, 2023
FDA inspection 1199978 · Voluntary Action Indicated (VAI) · Silvassa
Key facts
| Inspection ID | 1199978 |
|---|---|
| Firm | Jell Pharmaceuticals Pvt. Ltd. |
| FEI number | 3005205440 |
| Address | No 142/2 Athal Industrial Estate, Village Athal |
| City | Silvassa |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Mar 17, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data